Financial Performance - The company expects a net profit of approximately 30 million to 40 million yuan for the first half of 2024, a decrease of 88.44% to 84.59% compared to the same period in 2023, when the profit was 259.57 million yuan[11]. - Overall revenue is projected to grow by approximately 15% compared to the same period in 2023[12]. - The basic earnings per share are expected to be between 0.0053 yuan and 0.0070 yuan, down from 0.0464 yuan per share in the same period last year[11]. - The company will recognize equity incentive expenses of 64.0046 million yuan in the first half of 2024 due to the implementation of the employee stock ownership plan[4]. - The fair value of shares held in an innovative medical management company decreased by 63.7312 million yuan as of June 30, 2024, due to stock price fluctuations[13]. - The financial data provided is preliminary and has not been audited by an accounting firm[11]. Artificial Intelligence Business - The company's artificial intelligence business achieved significant progress, with expected revenue of about 34 million yuan from Nullmax for the first half of 2024, following its consolidation into the company's financial statements[6]. - Research and development expenses for the artificial intelligence segment are estimated to be around 70 million yuan for the first half of 2024, indicating a continued investment phase[6]. Operational Stability - The company’s overall operational situation is reported to be stable and orderly for the first half of 2024[12]. Investor Guidance - The company emphasizes the importance of cautious decision-making and awareness of investment risks for investors[14].
岩山科技(002195) - 2024 Q2 - 季度业绩预告